unsolicited application
The LIT - Leibniz Institute for Immunotherapy (foundation under civil law) (www.lit.eu), formerly RCI – is a biomedical research center focusing on
translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.
We offer:
- An international cutting-edge research environment that offers exciting and diverse opportunities
- Perspectives for further scientific qualification
- Possibility to visit collaborating centers
- Flexible working hours
- Flat hierarchies and short decision-making processes
- A highly motivated and cooperative team
- Job ticket
- Excellent funding situation and state-of-the-art equipment
The remuneration is based on TV-L.
The Leibniz Institute for Immunotherapy targets to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.
Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.
Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.